CDH2 and Familial prostate cancer: A cadherin switch (formed upon the suppression of E-cadherin and overexpression of N-cadherin) is involved in prostate cancer progression where E-cadherin obstruction by LEF1 and support of N-cadherin permit the cells to undergo epithelial-to-mesenchymal transition [77].